Funder: Alliance for Cancer Gene Therapy
Due Dates: June 1, 2024 (LOI) | September 15, 2024 (Full application, by invitation)
Funding Amounts: Up to $500,000 over 2–3 years (including max 10% indirect costs)
Summary: Supports research advancing cell and gene therapy solutions for pancreatic cancer, targeting its microenvironment and immune challenges.
Key Information: LOI required; research must be conducted at academic centers in the US or Canada.